Document Detail


Bacteriocins as alternative agents for control of multiresistant staphylococcal strains.
MedLine Citation:
PMID:  16478507     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: To investigate the activity of seven staphylococcins, bacteriocins produced by staphylococci, against multiresistant Staphylococcus aureus and coagulase-negative staphylococci (CNS) involved in human infections. METHODS AND RESULTS: Four bacteriocins produced by Staph. epidermidis (Pep5, epidermin, epilancin K7 and epicidin 280) and three produced by Staph. aureus (aureocins A70, A53 and 215FN) were tested. Sixteen Staph. aureus strains, including a representative strain of the endemic Brazilian methicillin-resistant clone (MRSA), and 57 CNS strains were used as indicators. Among the staphylococcins used, Pep5 was able to inhibit 77.2% of the CNS strains and 87.5% of the Staph. aureus strains tested, including the Brazilian MRSA endemic clone, responsible for a large number of hospital-acquired infections in Brazil. On the other hand, aureocin A53 and epidermin presented a high antagonistic activity only against the Staph. aureus strains, being able to inhibit, respectively, 87.5% and 81.3% of them, including also the Brazilian MRSA endemic clone. The remaining bacteriocins inhibited only a low percentage of the nosocomial staphylococcal strains tested. CONCLUSIONS: Aureocin A53 and epidermin have potential applications against MRSA, whereas Pep5 seems to be an attractive agent against both MRSA and CNS, including mupirocin-resistant strains and the Brazilian endemic clone of MRSA, which is also found disseminated in other countries. SIGNIFICANCE AND IMPACT OF THE STUDY: Bacteriocins may represent alternative agents to control important nosocomial pathogens.
Authors:
J S Nascimento; H Ceotto; S B Nascimento; M Giambiagi-Demarval; K R N Santos; M C F Bastos
Related Documents :
2344167 - Role of penicillinase plasmids in the stability of the meca gene in methicillin-resista...
1400957 - Latex agglutination-negative methicillin-resistant staphylococcus aureus recovered from...
20839557 - The environment as a factor in methicillin-resistant staphylococcus aureus transmission.
12523627 - Clonal and antibiotic resistance profiles of methicillin-resistant staphylococcus aureu...
19681957 - Extended-spectrum and cmy-type beta-lactamase-producing escherichia coli in clinical sa...
4553837 - Recombinant f' factors from escherichia coli k-12 strains carrying recb or recc.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Letters in applied microbiology     Volume:  42     ISSN:  0266-8254     ISO Abbreviation:  Lett. Appl. Microbiol.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-02-15     Completed Date:  2006-05-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8510094     Medline TA:  Lett Appl Microbiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  215-21     Citation Subset:  IM    
Affiliation:
Departamento de Microbiologia Geral, Instituto de Microbiologia Prof. Paulo de Góes, Universidade Federal do Rio de Janeiro, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / metabolism,  pharmacology*
Bacteriocins / metabolism,  pharmacology*
Brazil
Coagulase / metabolism
Humans
Methicillin Resistance / drug effects
Microbial Sensitivity Tests
Staphylococcal Infections / microbiology
Staphylococcus aureus / drug effects*,  enzymology,  metabolism
Staphylococcus epidermidis / metabolism
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Bacteriocins; 0/Coagulase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of a thermostable xylanase gene from Bacillus coagulans ST-6 in Lactococcus lactis.
Next Document:  16S rDNA directed PCR primers and detection of methanogens in the bovine rumen.